Pharmarise Holdings Corp. Statistics
Want to see JP:2796 full AI Analyst Report?
Pharmarise Holdings Corp. (2796) Stock Statistics & Valuation Metrics
Total Valuation
Pharmarise Holdings Corp. has a market cap or net worth of JPY 5.96B. The enterprise value is JPY 16.70B.
- Market Cap
- JPY 5.96B
- Enterprise Value
- JPY 16.70B
Share Statistics
Pharmarise Holdings Corp. has 12,069,231 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 12,069,231
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Pharmarise Holdings Corp.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.64%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 0.64%
- Return on Capital Employed (ROCE)
- 0.05
- Revenue Per Employee
- 34.23M
- Profits Per Employee
- 55.64K
- Employee Count
- 2,031
- Asset Turnover
- 2.13
- Inventory Turnover
- 21.65
Valuation Ratios
The current PE Ratio of Pharmarise Holdings Corp. is 59.72. Pharmarise Holdings Corp.’s PEG ratio is 0.16.
- PE Ratio
- 59.72
- PS Ratio
- 0.08
- PB Ratio
- 0.88
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.16
Income Statement
In the last 12 months, Pharmarise Holdings Corp. had revenue of 69.51B and earned 113.00M in profits. Earnings per share was 9.95.
- Revenue
- 69.51B
- Gross Profit
- 8.64B
- Operating Income
- 980.00M
- Pretax Income
- 698.00M
- Net Income
- 113.00M
- EBITDA
- 2.58B
- Earnings Per Share (EPS)
- 9.95
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Pharmarise Holdings Corp. pays an annual dividend of JPY 14.00, resulting in a dividend yield of 2.76%
- Dividend Per Share
- JPY 14.00
- Dividend Yield
- 2.76%
- Payout Ratio
- -165.68%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 1.63%
Stock Price Statistics
- Beta
- 0.09
- 52-Week Price Change
- -5.59%
- 50-Day Moving Average
- 505.44
- 200-Day Moving Average
- 502.12
- Relative Strength Index (RSI)
- 53.93
- Average Volume (3m)
- 6,380
Important Dates
Pharmarise Holdings Corp. upcoming earnings date is Dec 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 17, 2026
- Next Earnings Date
- Dec 17, 2026
- Ex-Dividend Date
- May 29, 2025
Financial Position
Pharmarise Holdings Corp. as a current ratio of 0.94, with Debt / Equity ratio of 221.46%
- Current Ratio
- 0.94
- Quick Ratio
- 0.74
- Debt to Market Cap
- 2.52
- Net Debt to EBITDA
- 3.54
- Interest Coverage Ratio
- 3.44
Taxes
In the past 12 months, Pharmarise Holdings Corp. has paid 591.00M in taxes.
- Income Tax
- 591.00M
- Effective Tax Rate
- 0.85
Enterprise Valuation
Pharmarise Holdings Corp. EV to EBITDA ratio is 6.68, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.24
- EV to EBITDA
- 6.68
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Pharmarise Holdings Corp. has JPY 2.94B in cash and marketable securities with JPY 13.83B in debt, giving a net cash position of -JPY 10.89B billion.
- Cash & Marketable Securities
- JPY 2.94B
- Total Debt
- JPY 13.83B
- Net Cash
- -JPY 10.89B
- Net Cash Per Share
- -JPY 902.21
- Tangible Book Value Per Share
- -JPY 60.51
Margins
Gross margin is 12.31%, with operating margin of 1.28%, and net profit margin of 0.14%.
- Gross Margin
- 12.31%
- Operating Margin
- 1.28%
- Pretax Margin
- 0.92%
- Net Profit Margin
- 0.14%
- EBITDA Margin
- 3.58%
- EBIT Margin
- 1.25%
Analyst Forecast
The average price target for Pharmarise Holdings Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 7.64%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 56

